Chart calendar AbbVie Inc.

3f65983e1b62fd7962.kV0XIp9ySpu-Y5b9e3OsKK_po6gABVTKCr_CAvAW_8c.2jNWUvERONrIVKfKMEb6fpuR6sptZzeFXMikW5RanLOnLCMU2Rt-rdQI_Q~68b615f978b163d25178051632649b66

Upcoming events on AbbVie Inc.

2024-10-14 Détachement de
2024-10-23 01:00 am BioProcess International Asia
2024-10-29 Q3 2024 Earnings Release Pre-market
2024-10-30 09:00 am Q3 2024 Earnings Call
2025-01-28 Q4 2024 Earnings Release (Projected)
2025-04-24 Q1 2025 Earnings Release (Projected)
2025-07-24 Q2 2025 Earnings Release (Projected)
2025-10-30 Q3 2025 Earnings Release (Projected)

Past events on AbbVie Inc.

2024-07-25 09:00 am Q2 2024 Earnings Call
2024-07-25 07:36 am Q2 2024 Earnings Release
2024-07-14 Détachement de
2024-06-12 10:00 am Goldman Sachs Global Healthcare Conference
2024-06-03 03:15 pm American Society of Clinical Oncology Meeting - Abstract No: 3515
2024-06-02 11:01 am American Society of Clinical Oncology Meeting - Abstract No: 103
2024-06-01 04:12 pm American Society of Clinical Oncology Meeting - Abstract No: 3001
2024-05-15 01:40 pm BofA Securities Health Care Conference
2024-05-03 10:00 am Annual General Meeting
2024-04-26 09:00 am Q1 2024 Earnings Call
2024-04-26 07:35 am Q1 2024 Earnings Release
2024-04-11 Détachement de
2024-03-27 11:30 am Anti-Aging and Aesthetics Medicine World Congress
2024-03-27 09:00 am Anti-Aging and Aesthetics Medicine World Congress
2024-03-27 06:15 am Anti-Aging and Aesthetics Medicine World Congress
2024-03-27 04:45 am Anti-Aging and Aesthetics Medicine World Congress
2024-03-14 09:00 am Barclays Global Healthcare Conference
2024-03-10 05:45 pm American Academy of Dermatology Meeting
2024-03-10 05:40 pm American Academy of Dermatology Meeting
2024-03-10 05:30 pm American Academy of Dermatology Meeting

Past dividends on AbbVie Inc.

2024-07-14 Quarterly 1.55 USD
2024-04-11 Quarterly 1.55 USD
2024-01-11 Quarterly 1.55 USD
2023-10-11 Quarterly 1.48 USD
2023-07-12 Quarterly 1.48 USD
2023-04-12 Quarterly 1.48 USD
2023-01-11 Quarterly 1.48 USD
2022-10-12 Quarterly 1.41 USD
2022-07-13 Quarterly 1.41 USD
2022-04-12 Quarterly 1.41 USD
2022-01-12 Quarterly 1.41 USD
2021-10-13 Quarterly 1.3 USD
2021-07-13 Quarterly 1.3 USD
2021-04-13 Quarterly 1.3 USD
2021-01-13 Quarterly 1.3 USD
2020-10-13 Quarterly 1.18 USD
2020-07-13 Quarterly 1.18 USD
2020-04-13 Quarterly 1.18 USD
2020-01-13 Quarterly 1.18 USD
2019-10-10 Quarterly 1.07 USD

Annual results

Fiscal PeriodDezember 2021 2022 2023 2024 2025 2026
Net sales
Million USD
Released
Forecast
Spread
56 122
56 238
-0.21%
58 054
58 284
-0.4%
54 318
54 047
0.5%

55 700


58 598


62 696

EBITDA
Million USD
Released
Forecast
Spread
29 018
29 168
-0.51%
30 961
31 181
-0.7%
25 545
25 858
-1.21%

25 749


28 498


31 238

EBIT
Million USD
Released
Forecast
Spread
28 215
28 167
0.17%
30 183
30 154
0.1%
24 793
24 926
-0.53%

24 836


27 637


30 460

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
12 989
12 579
3.26%
13 477
16 796
-19.76%
6 250
8 933
-30.04%

11 178


14 880


16 712

Net income
Million USD
Released
Forecast
Spread
11 542
11 140
3.61%
11 836
14 494
-18.34%
4 863
8 288
-41.32%

8 495


11 734


14 289

EPS
USD
Released
Forecast
Spread
6,45
6,25
3.27%
6,63
8,28
-19.89%
2,72
5,30
-48.69%

5,24


7,22


8,77

Announcement Date02/02/2209/02/2302/02/24-

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
14 812
14 944
-0.89%
15 121
15 337
-1.41%
12 225
12 230
-0.04%
13 865
13 520
2.55%
13 927
13 707
1.6%
14 301
14 027
1.96%
12 310
11 936
3.14%
14 462
14 027
3.1%

14 264


14 649


13 183


14 448


14 887


15 569

EBITDA
Million USD
Released
Forecast
Spread
8 090
8 645
-6.42%
8 072
8 405
-3.96%
5 682
5 686
-0.06%
6 710
6 633
1.16%
6 706
6 681
0.37%
6 447
6 600
-2.32%
5 378
5 444
-1.21%
6 342
6 781
-6.47%

6 847


6 979


6 037


7 276


7 143


7 246

EBIT
Million USD
Released
Forecast
Spread
7 909
7 843
0.85%
7 876
7 778
1.26%
5 503
5 553
-0.9%
6 520
6 398
1.9%
6 510
6 498
0.19%
6 260
6 391
-2.05%
5 195
5 158
0.71%
6 158
6 229
-1.14%

6 690


6 752


6 217


7 045


7 096


7 311

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread






475
5 059
-90.61%
2 610
3 685
-29.17%
1 953
3 960
-50.68%
1 212
3 839
-68.43%
1 755
2 367
-25.86%
2 146
3 226
-33.48%

3 385


3 393













Net income
Million USD
Released
Forecast
Spread
3 949
5 207
-24.16%
2 473
3 781
-34.59%
239
2 405
-90.06%
2 024
2 570
-21.25%
1 778
2 937
-39.46%
822
1 580
-47.98%
1 369
1 220
12.17%
1 370
1 912
-28.35%

2 284


2 500


1 818


2 169


2 368


2 651

EPS
USD
Released
Forecast
Spread
2,21
2,87
-22.91%
1,38
2,71
-49.14%
0,13
1,42
-90.82%
1,14
1,43
-20.46%
1,00
1,72
-41.86%
0,46
2,00
-76.95%
0,77
0,66
16.08%
0,77
1,49
-48.21%

1,48


1,43


1,02


1,22


1,34


1,50

Announcement Date28/10/2209/02/2327/04/2327/07/2327/10/2302/02/2426/04/2425/07/24------

Net sales - Quarter - Rate of surprise

quality-estimates-chart ABBVIE-INC

Quarterly earnings - Rate of surprise

quality-estimates-chart ABBVIE-INC

Net sales - Annual - Rate of surprise

quality-estimates-chart ABBVIE-INC

Annual profits - Rate of surprise

quality-estimates-chart ABBVIE-INC